Molina Healthcare (NYSE:MOH) Issues Quarterly Earnings Results, Beats Estimates By $0.19 EPS
by Jessica Moore · The Cerbat GemMolina Healthcare (NYSE:MOH – Get Free Report) posted its quarterly earnings results on Wednesday. The company reported $2.35 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.16 by $0.19, FiscalAI reports. The business had revenue of $10.80 billion for the quarter, compared to analysts’ expectations of $10.91 billion. Molina Healthcare had a return on equity of 13.60% and a net margin of 1.04%.
Molina Healthcare Trading Up 1.3%
NYSE MOH traded up $2.03 on Wednesday, reaching $153.03. The company had a trading volume of 2,588,255 shares, compared to its average volume of 1,757,444. The stock’s 50 day moving average is $143.54 and its 200-day moving average is $159.39. The stock has a market cap of $7.97 billion, a price-to-earnings ratio of 17.88 and a beta of 0.55. The company has a quick ratio of 1.69, a current ratio of 1.69 and a debt-to-equity ratio of 0.97. Molina Healthcare has a 52 week low of $121.06 and a 52 week high of $333.22.
Institutional Investors Weigh In On Molina Healthcare
A number of institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Quarry LP acquired a new stake in shares of Molina Healthcare during the fourth quarter worth about $32,000. Triumph Capital Management raised its position in shares of Molina Healthcare by 4,625.0% during the fourth quarter. Triumph Capital Management now owns 189 shares of the company’s stock worth $33,000 after purchasing an additional 185 shares during the period. Brown Brothers Harriman & Co. raised its position in shares of Molina Healthcare by 96.1% during the fourth quarter. Brown Brothers Harriman & Co. now owns 249 shares of the company’s stock worth $43,000 after purchasing an additional 122 shares during the period. MUFG Securities EMEA plc acquired a new stake in shares of Molina Healthcare during the second quarter worth about $48,000. Finally, DV Equities LLC acquired a new stake in shares of Molina Healthcare during the fourth quarter worth about $76,000. Institutional investors own 98.50% of the company’s stock.
Analyst Upgrades and Downgrades
Several research firms recently issued reports on MOH. TD Cowen decreased their price target on Molina Healthcare from $175.00 to $144.00 and set a “hold” rating on the stock in a report on Monday, February 9th. Weiss Ratings reiterated a “sell (d+)” rating on shares of Molina Healthcare in a report on Thursday, January 22nd. UBS Group set a $173.00 price objective on Molina Healthcare in a report on Friday, March 13th. Wall Street Zen upgraded Molina Healthcare from a “strong sell” rating to a “sell” rating in a report on Sunday. Finally, Mizuho dropped their price objective on Molina Healthcare from $220.00 to $180.00 and set an “outperform” rating for the company in a report on Thursday, March 12th. Two investment analysts have rated the stock with a Buy rating, ten have issued a Hold rating and two have given a Sell rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of $169.21.
View Our Latest Report on Molina Healthcare
About Molina Healthcare
Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.
The company traces its roots to the early 1980s, when Dr.